Our US Clinical Trial Site Analysis is a thorough analysis of the clinical trial site market in the USA. This report is valuable for clinical trial AI technology vendors wanting to improve market penetration in the US, or investors searching for acquisition targets in the rapidly consolidating CRO industry.
After careful analysis of the clinical trials in the US, this report provides a list of the 250 leading clinical trial sites in each of the 50 US states based on number of currently recruiting trials, as well as each sites therapeutic expertise and segmentation into research/academia, pharma/biotech, and clinics.
The following deliverables are included with the purchase of every report license.
- Excel data file with 102 data tables and figures
- Direct access to the lead analyst for questions and follow-ups